Monday, August, 19, 2019 05:33:37

Contribution By Sunil Hebbalkar


MediciNova announces outcomes of the SPRINT-MS Phase 2b Trial

This analysis was aimed to understand the types of progressive MS subjects that responds best to MN-166 (ibudilast) treatment MediciNova, Inc., the biopharmaceutical firm listed on the Tokyo Stock Exchange’s JASDAQ Market and NASDAQ Global Market, has reportedly announced outcomes of the SPRINT-MS Phase 2b …

Airbnb invests in OYO to strengthen its hotel booking business

Online hospitality service firm Airbnb has reportedly invested in OYO, the Indian hotel reservation start-up’s series E funding round, as it plans to further consolidate its stance in the hotel booking business. Neither of the companies have disclosed any details pertaining to the investment, which …